December 15, 2025: Study Shows that Zepbound May Not Reduce the Risk of Obesity-Related Cancers Earlier this year, researchers suggested that Zepbound, which many people take to lose weight, could lower someones risk of thirteen different obesity-related cancers
Patients should also be careful about combining Lexapro with other serotonergic agents unless a clinician is supervising the regimen
Injectable Semaglutide : Given via a prefilled pen on a weekly basis, which bypasses the digestive system entirely
Fat will feel like a pocket & often create a bulge or roll when grabbed, whereas loose skin will be stretchy & thin between the fingers & can be rolled or rubbed against each other with no substance in between
Monitor for potential consequences of delayed absorption of oral medications concomitantly administered with Saxenda Use in Specific Populations Saxenda should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus There are no data on the presence of liraglutide in human breast milk
A: Observational research suggests that people taking GLP-1 receptor agonists may have a lower risk of developing substance use disorders, but clinical trials are needed to confirm whether these drugs directly influence addiction